El Center for Experimental Therapeutics del OHSU Knight Cancer Institute ofrece conocimiento experto en farmacología, toxicología y química para el desarrollo de nuevos fármacos, junto con acceso a compuestos químicos, servicios de detección de alto rendimiento y una amplia gama de sistemas de prueba modelo. (OHSU/Christine Torres Hicks)

Leslie Muldoon, Ph.D. (left) talks with Edward Neuwelt, M.D., in the lab at OHSU. Neuwelt has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)

Leslie Muldoon, Ph.D. (left) talks with Edward Neuwelt, M.D., in the lab at OHSU. Neuwelt has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)

Edward Neuwelt, M.D., has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)

Edward Neuwelt, M.D., has spent more than 20 years researching pediatric hearing loss caused by platinum-based chemotherapies. A clinical trial based on his work has found a treatment protocol that reduces hearing loss by nearly 50 percent when treating a form of pediatric liver cancer. (OHSU/Kristyna Wentz-Graff)

Head, Division of Hematology and Medical Oncology, OHSU School of Medicine; Associate Director, Medical Oncology, OHSU Knight Cancer Institute. (OHSU)

Raymond Bergan, M.D., (left) talks with Ryan Gordon, Ph.D., in the OHSU Bergan Basic Research Laboratory, May 23, 2018. A multidisciplinary team has discovered a drug compound that stops cancer cells from spreading throughout the body. (OHSU/Kristyna Wentz-Graff)

(Left to right) Ryan Gordon, Ph.D., Raymond Bergan, M.D., Zhenzhen Zhang, Ph.D., M.P.H., Limin Zhang, Ph.D., Graham Fowler and Abhi Pattanayak in the OHSU Bergan Basic Research Laboratory, May 23, 2018. A multidisciplinary team has discovered a drug compound that stops cancer cells from spreading throughout the body. (OHSU/Kristyna Wentz-Graff)